Fifth Third Bancorp
KZIA

Fifth Third Bancorp’s Kazia Therapeutics KZIA Stock Holding History

Fifth Third Bancorp’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1
Closed – – 2292
2018
Q3 		$0 Buy
+1
New +$170 ﹤0.01% 2254

Other funds holding KZIA

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RE
RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Fifth Third Bancorp's KZIA Position: Q4 2018 in Review

Fifth Third Bancorp sold out of Kazia Therapeutics (KZIA) in Q4 2018, closing a stake of 1 share.

Fifth Third Bancorp first reported a position in KZIA in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 6 funds tracked by Wall St. Rank hold KZIA as of Q4 2018.

  • Fifth Third Bancorp reported no remaining Kazia Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Fifth Third Bancorp sold 1 Kazia Therapeutics share in Q4 2018.
  • Fifth Third Bancorp first reported a position in Kazia Therapeutics in Q3 2018 and held it in 1 quarter.
  • Fifth Third Bancorp's Kazia Therapeutics position peaked at $0 in Q3 2018.
  • 6 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q4 2018.

Based on Fifth Third Bancorp's 13F filing for Q4 2018, filed 14 Feb 2019.